Triple

T14720707
Position Surface form Disambiguated ID Type / Status
Subject Sankyo Company E345804 entity
Predicate partOf P40 FINISHED
Object Daiichi Sankyo
Daiichi Sankyo is a major Japanese global pharmaceutical company known for developing innovative medicines, particularly in cardiovascular disease and oncology.
 E1115557 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Daiichi Sankyo | Statement: [Sankyo Company, partOf, Daiichi Sankyo]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Daiichi Sankyo
Context triple: [Sankyo Company, partOf, Daiichi Sankyo]
  • A. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • B. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • C. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • D. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • E. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Daiichi Sankyo
Triple: [Sankyo Company, partOf, Daiichi Sankyo]
Generated description
Daiichi Sankyo is a major Japanese global pharmaceutical company known for developing innovative medicines, particularly in cardiovascular disease and oncology.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Daiichi Sankyo
Target entity description: Daiichi Sankyo is a major Japanese global pharmaceutical company known for developing innovative medicines, particularly in cardiovascular disease and oncology.
  • A. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • B. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • C. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • D. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • E. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d822e5911c8190ba589f957dbd9ba7 completed April 9, 2026, 10:06 p.m.
NER Named-entity recognition batch_69dec25d56fc8190871873ca55d49272 completed April 14, 2026, 10:40 p.m.
NED1 Entity disambiguation (via context triple) batch_69fdf0957bb081908f1f382f3be8ec20 completed May 8, 2026, 2:17 p.m.
NEDg Description generation batch_69fdf440a03c8190886119ab3c8ab610 completed May 8, 2026, 2:33 p.m.
NED2 Entity disambiguation (via description) batch_69fdf4f2acbc8190b51ee456093a2813 completed May 8, 2026, 2:36 p.m.
Created at: April 10, 2026, 1:29 a.m.